INTERNATIONAL PATENT: RADELLA PHARMACEUTICALS LLC FILES APPLICATION FOR "PEPTIDE-BASED INHIBITORS OF PTP1B / NCK1 INTERACTION AND METHODS OF MAKING AND USING SAME"

GENEVA, March 11 -- RADELLA PHARMACEUTICALS LLC (1209 Orange StreetWilmington, DE 19801) filed a patent application (PCT/US2025/043749) for "PEPTIDE-BASED INHIBITORS OF PTP1B / NCK1 INTERACTION AND METHODS OF MAKING AND USING SAME" on Aug 27, 2025. With publication no. WO/2026/050386, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DALL'ANGELO, Sergio (c/o Radella Pharmaceuticals LLC1209 Orange StreetWilmington, DE 19801), HAMER, Meghan, Marie (c/o Radella Pharmaceuticals LLC1209 Orange StreetWilmington, DE 19801), MARTIN...